Company / Revenue per Share
NEUROONE MEDICAL TECHNOLOGIES Corp Revenue per Share History
FY2011-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$0.11
FY2025
5-year range
$0.01 / $0.11
FY2021-FY2025
Trend
+37.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Revenue per Share has fluctuated over the past 10 years, ranging from $0.00 in FY2016 to $0.11 in FY2025.
Based on SEC 10-K filings.
0.11 in FY2025 with a 10-year CAGR of +93.5%.
Improved from $0.01 to $0.11 over the past 2 years.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- +96.2%
- 5-Year CAGR
- -
- 10-Year CAGR
- +93.5%
Key checks
Key Insights
- In FY2025, revenue per share increased 37.3% year-over-year.
- Lowest revenue per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -2.54 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.11 | +37.3% |
| FY2024 | $0.08 | +673.0% |
| FY2023 | $0.01 | -28.8% |
| FY2022 | $0.01 | -38.4% |
| FY2021 | $0.02 | - |
| FY2016 | $0.00 | -100.0% |
| FY2015 | $0.00 | -38.1% |
| FY2014 | $0.00 | -76.9% |
| FY2012 | $0.00 | +310.3% |
| FY2011 | $0.00 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026